Detalhe da pesquisa
1.
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
Br J Cancer
; 130(2): 269-274, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030749
2.
A Population-Based Study of Genes Previously Implicated in Breast Cancer.
N Engl J Med
; 384(5): 440-451, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471974
3.
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations.
Hered Cancer Clin Pract
; 22(1): 7, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38741145
4.
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Cancer
; 129(6): 901-907, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571512
5.
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
Br J Cancer
; 128(12): 2283-2294, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076566
6.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Breast Cancer Res Treat
; 201(2): 257-264, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432545
7.
Promotores' perspectives on the virtual adaptation of a hereditary breast cancer education program.
J Genet Couns
; 32(6): 1226-1231, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37747056
8.
Differences in somatic TP53 mutation type in breast tumors by race and receptor status.
Breast Cancer Res Treat
; 192(3): 639-648, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35286522
9.
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT.
Clin Genet
; 101(3): 317-323, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897671
10.
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 164(3): 514-521, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063280
11.
Cancer health disparities in racial/ethnic minorities in the United States.
Br J Cancer
; 124(2): 315-332, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32901135
12.
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 187(2): 515-523, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423179
13.
Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 159(3): 820-826, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010967
14.
Urinary cadmium and timing of menarche and pubertal development in girls.
Environ Res
; 183: 109224, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32085996
15.
Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers.
Int J Gynecol Cancer
; 30(6): 825-830, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354794
16.
Assessing the performance of in silico methods for predicting the pathogenicity of variants in the gene CHEK2, among Hispanic females with breast cancer.
Hum Mutat
; 40(9): 1612-1622, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31241222
17.
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry.
Hum Mutat
; 40(10): 1781-1796, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112363
18.
Environmental exposures during windows of susceptibility for breast cancer: a framework for prevention research.
Breast Cancer Res
; 21(1): 96, 2019 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31429809
19.
Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas.
Breast Cancer Res
; 21(1): 3, 2019 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30642363
20.
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Cancer
; 125(16): 2829-2836, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31206626